» Articles » PMID: 25809635

PD-1 Alters T-cell Metabolic Reprogramming by Inhibiting Glycolysis and Promoting Lipolysis and Fatty Acid Oxidation

Overview
Journal Nat Commun
Specialty Biology
Date 2015 Mar 27
PMID 25809635
Citations 621
Authors
Affiliations
Soon will be listed here.
Abstract

During activation, T cells undergo metabolic reprogramming, which imprints distinct functional fates. We determined that on PD-1 ligation, activated T cells are unable to engage in glycolysis or amino acid metabolism but have an increased rate of fatty acid β-oxidation (FAO). PD-1 promotes FAO of endogenous lipids by increasing expression of CPT1A, and inducing lipolysis as indicated by elevation of the lipase ATGL, the lipolysis marker glycerol and release of fatty acids. Conversely, CTLA-4 inhibits glycolysis without augmenting FAO, suggesting that CTLA-4 sustains the metabolic profile of non-activated cells. Because T cells utilize glycolysis during differentiation to effectors, our findings reveal a metabolic mechanism responsible for PD-1-mediated blockade of T-effector cell differentiation. The enhancement of FAO provides a mechanistic explanation for the longevity of T cells receiving PD-1 signals in patients with chronic infections and cancer, and for their capacity to be reinvigorated by PD-1 blockade.

Citing Articles

CRSP8-driven fatty acid metabolism reprogramming enhances hepatocellular carcinoma progression by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling.

Lin Y, Liang Z, Weng Z, Liu X, Zhang F, Chong Y J Exp Clin Cancer Res. 2025; 44(1):93.

PMID: 40069732 PMC: 11895297. DOI: 10.1186/s13046-025-03329-3.


Immunosenescence promotes cancer development: from mechanisms to treatment strategies.

Wang L, Tang D Cell Commun Signal. 2025; 23(1):128.

PMID: 40065335 PMC: 11892258. DOI: 10.1186/s12964-025-02082-6.


A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8 T cell fitness in solid tumours.

Pretto S, Yu Q, Bourdely P, Trusso Cafarello S, Van Acker H, Verelst J Nat Metab. 2025; .

PMID: 40065102 DOI: 10.1038/s42255-025-01233-w.


The emerging role of glycolysis and immune evasion in ovarian cancer.

Jin B, Miao Z, Pan J, Zhang Z, Yang Y, Zhou Y Cancer Cell Int. 2025; 25(1):78.

PMID: 40045411 PMC: 11881340. DOI: 10.1186/s12935-025-03698-x.


Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


References
1.
Schoenborn V, Heid I, Vollmert C, Lingenhel A, Adams T, Hopkins P . The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes. Diabetes. 2006; 55(5):1270-5. DOI: 10.2337/db05-1498. View

2.
Warburg O . On respiratory impairment in cancer cells. Science. 1956; 124(3215):269-70. View

3.
Duncan R, Wang Y, Ahmadian M, Lu J, Sarkadi-Nagy E, Sul H . Characterization of desnutrin functional domains: critical residues for triacylglycerol hydrolysis in cultured cells. J Lipid Res. 2009; 51(2):309-17. PMC: 2803232. DOI: 10.1194/jlr.M000729. View

4.
St-Pierre J, Drori S, Uldry M, Silvaggi J, Rhee J, Jager S . Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006; 127(2):397-408. DOI: 10.1016/j.cell.2006.09.024. View

5.
Zaugg K, Yao Y, Reilly P, Kannan K, Kiarash R, Mason J . Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 2011; 25(10):1041-51. PMC: 3093120. DOI: 10.1101/gad.1987211. View